Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sen...
Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sensing Approach
Gastric cancer has good chances to be cured if diagnosed at an early stage; currently, there is lack of a reliable non-invasive screening tool. Eastern Europe and Latin America are among the geographical areas with high burden of...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CTQ2013-47993-P
METODOLOGIAS RAPIDAS PARA LA DETECCION Y CUANTIFICACION DE B...
111K€
Cerrado
SWEATPATCH
Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeu...
3M€
Cerrado
VOLATEVS
Analysis of the volatile organic compounds emitted by extrac...
1M€
Cerrado
EQC2019-005785-P
Adquisición de cromatógrafo de gases-detector de espectromet...
221K€
Cerrado
EXCEED
Exosome Characterization Platform for Early Detection of Bre...
269K€
Cerrado
PID2021-126543OB-C21
PROCESADO DE SEÑAL Y APRENDIZAJE AUTOMATICO PARA CROMATOGRAF...
200K€
Cerrado
Información proyecto VOGAS
Duración del proyecto: 45 meses
Fecha Inicio: 2018-12-14
Fecha Fin: 2022-09-30
Descripción del proyecto
Gastric cancer has good chances to be cured if diagnosed at an early stage; currently, there is lack of a reliable non-invasive screening tool. Eastern Europe and Latin America are among the geographical areas with high burden of the disease.
This project is aiming at developing a non-invasive gastric cancer screening tool by detecting characteristic panels of volatile organic compounds (VOCs). The mechanisms of VOC origin and their composition in gastric cancer patients will be addressed via headspace analysis of cancer tissue, cell-lines, and bacterial flora; VOCs identified during this analysis will be compared to the compounds present in human breath, both via gas chromatography coupled to mass spectrometry (GC-MS).
Based on this data, a new type of breath analyser will be developed and validated building upon previously acquired expertise of the consortium members. Specifically, the exhaled breath analyser will combine electronic nose concepts utilizing gold nanoparticles and metal oxide sensors with orthogonal mid-infrared spectroscopic techniques for obtaining multi-dimensional analytical data sets; furthermore, compact pre-concentration schemes will be evaluated. All components will be integrated into several prototypes of portable and optimized devices.
The clinical studies will be conducted in parallel in European (Latvia, Ukraine) and Latin American (Colombia, Brazil, Chile) countries with high disease burden. Patients with gastric cancer and individuals with and without precancerous lesions (dysplasia, atrophy, intestinal metaplasia) will be enrolled. The role of confounding factors including H.pylori infection will be addressed.
As the main result, we expect to provide the first reliable non-invasive gastric cancer screening device based on exhaled breath analysis concepts for future large-scale implementation. The development of according research competences and international collaborations therefore is the most vital component of this project.